Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Inetetamab|DRUG: Pyrotinib|DRUG: Oral Vinorelbine Tartrate
Sponsor: The First Affiliated Hospital with Nanjing Medical University